UNCY
Unicycive Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$0.638
Максимум
$0.638
Минимум
$0.638
Объем
4.18M
Фундаментальные показатели компании
Статистические данные торговли
Связанные новости
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.
Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh
Связанные акции
MSD
Morgan Stanley Emerging Markets Debt Fund Inc.
IGR
CBRE Global Real Estate Income Fund Common Shares of Beneficial Interest
WOW
WideOpenWest Inc.
ADTN
ADTRAN Holdings Inc.
ABLVW
Able View Global Inc. Warrant
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.